在糖尿病足中,介细胞干细胞衍生的细胞外囊的保护作用和分子机制
Jian Zhao1, Yan Gu1, Peng Hou1
1Department of Vascular Surgery, Tianjin First Central Hospital, Tianjin, China.
Cellular reprogramming
|November 29, 2024
概括
介酶干细胞衍生的细胞外囊泡 (MSC-EVs) 通过输送microRNA-21-5p (miR-21-5p) 来促进糖尿病足的愈合. 这一过程通过准克鲁佩尔类因子6 (KLF6) 来增强皮肤细胞的增殖和迁移.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 糖尿病足 (DFU) 是一个重大的临床挑战,有效治疗方法有限.
- 介细胞干细胞 (MSCs) 显示治疗潜力,但它们衍生的细胞外囊泡 (EVs) 提供了一个无细胞的替代品.
- 了解MSC-EV在伤口愈合中的分子机制对于治疗开发至关重要.
研究的目的:
- 研究糖尿病患者中人类带MSC衍生的EVs (HucMSC-EVs) 的保护机制.
- 确定HucMSC-EVs传递的microRNA-21-5p (miR-21-5p) 在促进人类皮肤纤维细胞 (HSF) 功能方面的作用.
- 阐明涉及HucMSC-EV介导的HSF调制中的克鲁佩尔类因子6 (KLF6) 的分子途径.
主要方法:
- 描述了HucMSCs,并通过使用TEM,NTA和西方涂抹隔离和验证了EVs.
- 用PKH67标记的HucMSC-EVs和Cy3标记的miR-21-5p对待HSF来评估吸收.
- 细胞增殖,迁移和基因/蛋白质表达 (miR-21-5p,KLF6) 通过使用各种测试 (CCK-8,殖民地形成,划痕,Transwell,qRT-PCR,西部斑点) 进行了分析.
- 一个双化酶记者测定证实了miR-21-5p和KLF6.6之间的相互作用.
主要成果:
- 成功隔离和表征HucMSC-EV,并确认它们被HSF吸收.
- 在高葡萄糖条件下,HucMSC-EVs显著增强了HSF的增殖和迁移.
- 确定miR-21-5p的EV输送是关键机制,准和抑制KLF6表达.
- KLF6的过度表达逆转了HucMSC-EVs引起的增殖和迁移效应.
结论:
- 由HucMSC衍生的EVs通过传递miR-21-5p来促进HSF的扩散和迁移,这降低了KLF6.
- 这个miR-21-5p/KLF6轴代表了DFU治疗的新治疗目标.
- 作为加速糖尿病伤口愈合的无细胞治疗策略,HucMSC-EVs具有前景.
更多相关视频
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.0K
09:10A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
Published on: June 23, 2022
1.4K
相关概念视频
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:05Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K